Literature DB >> 24012624

Choroidal metastasis secondary to prostatic adenocarcinoma: case report and review of literature.

Faisal Albadainah1, Jamal Khader2, Samer Salah1, Ahmed Salem3.   

Abstract

Choroidal metastasis from prostate adenocarcinoma is exceedingly rare. Furthermore, data addressing the optimal therapeutic strategy is limited. A 62-year-old male patient with metastatic prostate cancer was found to have a choroidal metastasis after complaining of decreased vision in his left eye. Following treatment with external beam radiotherapy, complete response in the choroidal metastasis was demonstrated. A literature search was undertaken to highlight the therapeutic options for this rare presentation. Choroidal metastasis secondary to adenocarcinoma of the prostate is exceedingly rare, as only eight cases have been reported so far. External beam radiotherapy is an effective therapeutic modality.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Androgen deprivation; Choroid; Neoplasm metastasis; Prostate cancer; Radiation therapy

Mesh:

Year:  2013        PMID: 24012624     DOI: 10.1016/j.hemonc.2013.08.002

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  3 in total

1.  Serum markers change for intraocular metastasis in renal cell carcinoma.

Authors:  Tie Sun; Jing Tang; Yi-Cong Pan; Chen-Yu Yu; Biao Li; Li-Juan Zhang; Hui-Ye Shu; Qian-Min Ge; Yi Shao
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

2.  Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma.

Authors:  Qiu-Yu Li; Ting Su; Wen-Qing Shi; Jian-Wen Fang; Meng-Yao Zhang; Qian-Hui Xu; Rong-Bin Liang; Qian-Min Ge; Biao Li; Yi Shao
Journal:  Dis Markers       Date:  2022-04-23       Impact factor: 3.434

3.  Prostate Cancer Detected by Choroidal Tumor and Complete Response to Hormonal Therapy: Case Report and Literature Review of 24 Patients With Choroidal Metastasis From Prostate Cancer.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Aya Nakamura; Koichiro Wada
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.